Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas
Clinical trial NCT03030417 · COMPLETED
Trial details
- NCT number
- NCT03030417
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-27
- Primary completion
- 2023-10-02
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.